V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

ICU Medical Executive Compensation (FY25)

ICUI · Executive and director compensation, fiscal 2023 to 2025
Data as of September 7, 2026Latest filing (8-K): May 18, 2026
227 figures on this page: 217 cited to the filing that reported them, 10 calculated from figures it prints. See the citations
Vivek Jain, Chairman of the Board and Chief Executive Officer, received $6,452,042 in total compensation for fiscal 2025, and Jain's total moved 0.0% lower from the $6,454,754 reported for fiscal 2024. The say-on-pay proposal drew 95.8% support at the meeting held May 13, 2026 for fiscal 2025. Companies named in the disclosed peer group include Enovis, Envista Holdings, Haemonetics, Hologic and Integer Holdings, among others. The company reported 5 named executive officers for fiscal 2025.
Chief executive, fiscal 2025
◇
Vivek Jain
Latest say-on-pay support
=
May 13, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Vivek Jain: $6,454,754 → $6,452,042 (0.0% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is ICU Medical's chief executive and what were they paid?
Vivek Jain, Chairman of the Board and Chief Executive Officer, received $6,452,042 in total compensation for fiscal 2025. Jain's total moved 0.0% lower from the $6,454,754 reported for fiscal 2024.
What was ICU Medical's say-on-pay result?
The say-on-pay proposal drew 95.8% support at the meeting held May 13, 2026 for fiscal 2025.
Which companies are in ICU Medical's peer group?
Companies named in the disclosed peer group include Enovis, Envista Holdings, Haemonetics, Hologic and Integer Holdings, among others.
What is ICU Medical's chief executive pay ratio?
The company reported a chief executive pay ratio of 474:1 for fiscal 2025, against median employee compensation of $13,587.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Vivek Jain
Chairman of the Board and Chief Executive Officer
◇—◇—◇—◇◇
Christian Voigtlander
Chief Operating Officer
◇—◇—◇—◇◇
Brian Bonnell
Chief Financial Officer
◇◇◇—◇—◇◇
Virginia Sanzone
Corporate Vice President, General Counsel
◇◇◇—◇—◇◇
Daniel Woolson
Corporate Vice President, General Manager - Infusion Systems
◇◇◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Vivek Jain
Chairman of the Board and Chief Executive Officer
◇—◇—◇—◇◇
Christian Voigtlander
Chief Operating Officer
◇◇◇—◇—◇◇
Brian Bonnell
Chief Financial Officer
◇◇◇—◇—◇◇
Virginia Sanzone
Corporate Vice President, General Counsel
◇◇◇—◇—◇◇
Daniel Woolson
Corporate Vice President, General Manager - Infusion Systems
◇—◇—◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Vivek Jain
Chairman of the Board and Chief Executive Officer
◇—◇—◇—◇◇
Christian Voigtlander
Chief Operating Officer
◇—◇—◇——◇
Brian Bonnell
Chief Financial Officer and Treasurer
◇—◇—◇——◇
Virginia Sanzone
Corporate Vice President, General Counsel
◇—◇—◇——◇
Daniel Woolson
President
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Brian BonnellRSU———◇——◇
Brian BonnellRSU———◇——◇
Brian BonnellRSU———◇——◇
Christian VoigtlanderRSU———◇——◇
Christian VoigtlanderRSU———◇——◇
Christian VoigtlanderRSU———◇——◇
Daniel WoolsonRSU———◇——◇
Daniel WoolsonRSU———◇——◇
Daniel WoolsonRSU———◇——◇
Virginia SanzoneRSU———◇——◇
Virginia SanzoneRSU———◇——◇
Virginia SanzoneRSU———◇——◇
Vivek JainRSU———◇——◇
Vivek JainRSU———◇——◇
Vivek JainRSU———◇——◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Daniel WoolsonRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Virginia SanzoneRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Vivek JainRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Brian BonnellRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Christian VoigtlanderRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
David C. Greenberg
Lead independent director
◇◇————◇
David F. Hoffmeister
◇◇————◇
Elisha W. Finney
◇◇————◇
Kolleen T. Kennedy
◇◇————◇
Donald M. Abbey
◇◇————◇
Laurie Hernandez
◇◇————◇
Vivek Jain served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Audit committee chair◇
Compensation committee chair◇
Nominating and governance chair◇
Equity is delivered as restricted stock units.
Stock ownership guideline: 3x annual base retainer within 5 years of joining the Board

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Enovis ENOV
  • Envista Holdings NVST
  • Haemonetics HAE
  • Hologic HOLX
  • Integer Holdings ITGR
  • Integra LifeSciences Holdings IART
  • Masimo MASI
  • Merit Medical Systems MMSI
  • Sotera Health Company SHC
  • STERIS plc STE
  • Teleflex TFX
  • The Cooper Companies COO

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 13, 2026=◇◇◇
2024May 13, 2025=◇◇◇
2023May 15, 2024=◇◇◇
2022May 17, 2023=◇◇◇
2021May 17, 2022=◇◇◇
2020May 11, 2021=◇◇◇
2019May 13, 2020=◇◇◇
2018May 15, 2019=◇◇◇
2017May 15, 2018=◇◇◇
2015May 16, 2016=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when ICU Medical files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact ICU Medical disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where ICU Medical sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether ICU Medical's disclosed peer group is defensible, who names ICU Medical back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
227 figures on this page: 217 cited to the filing that reported them, 10 calculated from figures it prints.
217 cited to the filing
10 calculated from the filing

Documents cited

  1. 0000883984-26-000031
  2. 0000883984-26-000019
    2025 Director Compensation Table · CEO Pay Ratio · Director Compensation · Grants of Plan-Based Awards · and 2 more sections
  3. 0000883984-25-000018
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0000883984-25-000010
    Summary Compensation Table
  5. 0000883984-24-000018
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0000883984-24-000010
    Summary Compensation Table
  7. 0000883984-23-000024
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0000883984-22-000032
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0000883984-21-000016
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0000883984-20-000026
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0000883984-19-000019
    Item 5.07 Submission of Matters to a Vote of Security Holders
  12. 0000883984-18-000019
    Item 5.07 Submission of Matters to a Vote of Security Holders
  13. 0000883984-16-000065
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “ICU Medical executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/ICUI (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about ICU Medical and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers ICU Medical discloses

The companies named in ICUI's own disclosed peer group.

EnovisEnvista HoldingsHaemoneticsHologicInteger HoldingsIntegra LifeSciences HoldingsMasimoMerit Medical SystemsSTERIS plcTeleflexThe Cooper Companies

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy